Table 2.
Comparing mean values of Hb, MCV, RDW, UMMA, BMI, and CD4 parameters among study groups by ANOVA.
| Parameters |
Control | Naïve | Zt | NZt |
p value |
|---|---|---|---|---|---|
| n = 20 | n = 29 | n = 31 | n = 34 | ||
| Hb (g/dL) | 12.80 | 11.40 | 10.10 | 11.70 | 0.008 |
| MCV (fL) | 82.90 | 85.90 | 93.00 | 97.40 | 0.001 |
| RDW-SD (fL) | 43.50 | 50.60 | 58.50 | 55.80 | 0.028 |
| UMMA (mg/24 hrs) | 2.85 | 40.00 | 10.20 | 7.70 | 0.001 |
| BMI (kg/m2) | 25.4 | 24.68 | 22.92 | 23.03 | 0.377 |
| CD4 (cells/µL) | 306 | 304 | 261 | 310 | 0.613 |
UMMA, urine methylmalonic acid; MCV, mean cell volume; RDW, red cell distribution width; Hb, haemoglobin concentration; BMI, body mass index; CD4, cluster of differentiation 4; naïve, HIV positive treatment naïve subjects; Zt, zidovudine based treatment group; NZt, non-zidovudine-based treatment group. p value (significant level for ANOVA statistics). Post hoc statistics: show significant mean difference in ZT versus NZt group for Hb, MCV, and RDW-SD (p < 0.05).